By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


International AIDS Vaccine Initiative 

110 William Street

New York  New York  10038-3901  U.S.A.
Phone: 212-847-1111 Fax: 212-847-1112


Company News
New Microsphere-Based Methods For Detecting HIV Antibodies, International AIDS Vaccine Initiative Study 5/24/2013 8:25:35 AM
International AIDS Vaccine Initiative Welcomes New Members to Board of Directors 7/31/2012 9:52:37 AM
International AIDS Vaccine Initiative Welcomes Louis Schwartz as Chief Financial Officer 5/30/2012 9:53:12 AM
International AIDS Vaccine Initiative, GlycoMimetics, Inc., and Glycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate 5/9/2012 10:31:56 AM
International AIDS Vaccine Initiative and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 2/21/2012 12:10:01 PM
Mary Tydings, Managing Director at Russell Reynolds Associates, Joins International AIDS Vaccine Initiative Board 11/1/2011 11:48:40 AM
AIDS Researchers Isolate New Potent and Broadly Effective Antibodies Against HIV, International AIDS Vaccine Initiative, The Scripps Research Institute, Theraclone Sciences, Inc., and Monogram Biosciences (MGRM) Study 8/18/2011 7:50:02 AM
International AIDS Vaccine Initiative Appoints Margaret McGlynn President & Chief Executive Officer 7/8/2011 6:31:21 AM
Crucell N.V. (CRXL) and Beth Israel Deaconess Medical Center Join Forces with International AIDS Vaccine Initiative to Advance AdVac(R)-based AIDS Vaccine 8/11/2010 9:04:45 AM
Senior Merck & Co., Inc. (MRK) Executive to Head International AIDS Vaccine Initiative’s AIDS Vaccine Design and Development Laboratory 8/10/2010 9:31:45 AM